Correction: Mitochondrial Transplantation Therapy for Ischemic Stroke: Progress and Challenges (Cellular and Molecular Neurobiology, (2026), 46, 1, (46), 10.1007/s10571-026-01682-1)

In this article, Fig. 4 appeared incorrectly. For completeness and transparency, both the old incorrect and correct versions of the figure are displayed below. Incorrect Fig. 4: Correct Fig. 4: Key signaling pathways and molecules associated with mitochondrial therapeutic effects. This schematic summarizes the key molecular networks and pathways through which mitochondrialtargeted therapies exert their beneficial effects. These mechanisms involve mitigating oxidative stress, inhibiting gilal and inflammatory activation, reducing cell death, promoting neuroplasticity and neurogenesis. These pathways collectively represent promising targets for therapeutic interventions in mitochondrial transplantation in ischemic stroke The original article has been updated.